Liver Frailty Index for Prediction of Short-Term Rehospitalization in Patients with Liver Cirrhosis.
complications of cirrhosis
end-stage liver disease
extrahepatic features of chronic liver disease
functional decline
point-of-care diagnostic
sarcopenia
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
24 Apr 2022
24 Apr 2022
Historique:
received:
02
03
2022
revised:
15
04
2022
accepted:
22
04
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
29
5
2022
Statut:
epublish
Résumé
Background: Stratifying patients with liver cirrhosis for risk of rehospitalization is challenging with established scoring systems for chronic liver disease. Frailty captures the physical characteristics of patients with cirrhosis. Its value for predicting short-term rehospitalizations in hospitalized patients remains to be defined. Methods: Eighty-three non-electively hospitalized patients with liver cirrhosis were analyzed in this study. Frailty was assessed during the last 48 h of hospital stay with the liver frailty index (LFI). Patients were followed for 30-day rehospitalization. Results: In total, 26 (31%) patients were rehospitalized within 30 days. The median LFI was 4.5, and 43 (52%) patients were identified as frail. Rehospitalized patients had a significant higher LFI compared to patients without a rehospitalization within 30 days. In multivariable analysis, LFI as a metric variable (OR 2.36, p = 0.02) and lower platelet count (OR 0.98, p < 0.01) were independently associated with rehospitalization. LFI and its subtest chair stands had the best discriminative ability to predict rehospitalization, with AUROCs of 0.66 and 0.67, respectively. An LFI cut-off of >4.62 discriminated best between patients with and without elevated risk for rehospitalization within 30 days. Conclusions: Measures of frailty could be useful to identify patients at higher risk for short-term rehospitalization.
Identifiants
pubmed: 35626226
pii: diagnostics12051069
doi: 10.3390/diagnostics12051069
pmc: PMC9139749
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Clin Nutr. 2020 Dec;39(12):3533-3562
pubmed: 33213977
Liver Transpl. 2001 Jul;7(7):567-80
pubmed: 11460223
Hepatology. 2021 Sep;74(3):1611-1644
pubmed: 34233031
J Hepatol. 2019 Jan;70(1):172-193
pubmed: 30144956
Hepatology. 2022 Mar;75(3):600-609
pubmed: 34528267
Clin Geriatr Med. 2011 Feb;27(1):1-15
pubmed: 21093718
Gastroenterology. 2019 May;156(6):1675-1682
pubmed: 30668935
Hepatol Commun. 2022 Jan;6(1):237-246
pubmed: 34558844
Clin Interv Aging. 2014 Mar 19;9:433-41
pubmed: 24672230
BMC Geriatr. 2008 Oct 13;8:27
pubmed: 18851754
Nat Clin Pract Gastroenterol Hepatol. 2004 Dec;1(2):98-105
pubmed: 16265071
Br J Surg. 1973 Aug;60(8):646-9
pubmed: 4541913
Liver Transpl. 2021 Dec;27(12):1701-1703
pubmed: 34338440
Eur J Gastroenterol Hepatol. 2017 Dec;29(12):1416-1423
pubmed: 29016470
Hepatology. 2017 Aug;66(2):564-574
pubmed: 28422306
Dig Dis Sci. 2020 Dec;65(12):3734-3743
pubmed: 31982996
Liver Transpl. 2021 Dec;27(12):1711-1722
pubmed: 34018303
Am J Med. 2021 Dec;134(12):1530-1538
pubmed: 34464599
Hepatology. 2008 Aug;48(2):557-66
pubmed: 18627001
Hepatology. 2015 Aug;62(2):584-90
pubmed: 25846824